✦ LIBER ✦

Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study

✍ Scribed by Sun, Y; Jurgovsky, K; Möller, P; Alijagic, S; Dorbic, T; Georgieva, J; Wittig, B; Schadendorf, D

Book ID: 110038179
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 201 KB
Volume: 5
Category: Article
ISSN: 0969-7128
DOI: 10.1038/sj.gt.3300619

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic vaccination against metastat

Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial

✍ Angela Märten; Dimitri Flieger; Sabine Renoth; Silvia Weineck; Peter Albers; Mar 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 365 KB

P135 Vaccination of myeloma patients wit

P135 Vaccination of myeloma patients with monoclonal immunoglobulin loaded dendritic cells: preclinical and first clinical results of a phase I/II clinical trial

✍ D. Očadlíková; L. Zahradová; L. Kovářová; J. Smejkalová; L. Pour; P. Vidláková; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A phase I clinical trial of immunotherap

A phase I clinical trial of immunotherapy with interferon-γ gene-modified autologous melanoma cells : Monitoring the humoral immune response

✍ Zeinab Abdel-Wahab; Christina Weltz; Dina Hester; Nancy Pickett; Carol Vervaert; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

and then 18 million for the fifth and sixth injections. The humoral immune responses of the patients were assessed by enzyme-linked immunoadsorbent assay, radioimmunoassay, and radioimmunoprecipitation. ## RESULTS. Thirteen of the 20 patients completed the immunization protocol. Eight of these 13

Phase I study to the immunotherapy of me

Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene

✍ G. Stingl; E.-B. Bröcker; R. Mertelsmann; K. Wolff; S. Schreiber; E. Kämpgen; A. 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 52 KB

Allogeneic gene-modified tumor cells (RC

Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study

✍ Westermann, J; Flörcken, A; Willimsky, G; van Lessen, A; Kopp, J; Takvorian, A; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 715 KB

A phase-I clinical study of autologous t

A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer

✍ Hendrik Veelken; Andreas Mackensen; Michael Lahn; Gabriele Köhler; Daniel Becker 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 257 KB 👁 2 views

Tumor cells transfected to express immunostimulatory cytokines, or admixed with similarly modified bystander cells, are able to induce immune responses against unmodified tumor cells in animal models. For treatment of human patients, a vaccine composed of autologous tumor cells and IL-2-secreting al